AIMA
DEAD

Serial Number

97808575

Owner

Aima Inc.

Attorney

Lisa M. Caldwell

Filing Date

Feb 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AIMA Trademark

Serial Number: 97808575

AIMA is a trademark filed by Aima Inc. on February 23, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

Aima Inc. (2 trademarks)

Suite 3200
Vancouver, BC V6B4P7 , CA

Entity Type: 03

Trademark Details

Filing Date

February 23, 2023

Registration Date

Not Registered

Goods & Services

Downloadable software in the nature of computer software or mobile application software for managing, analyzing and storing patient health or medical information to provide recommendations for products and services in the fields of health and wellbeing and to provide information about clinical trial and drug trial criteria and qualification

menstrual symptom treatment preparations; nutraceutical dietary supplement for maintaining general health and wellbeing; nutraceutical food and beverages for general health and well-being; nutraceuticals as a sleep aid; nutraceuticals for reducing stress and fatigue; nutraceuticals for relieving anxiety; nutraceuticals for the relief of epilepsy; nutraceuticals for the relief of pain; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of pain; topical analgesic creams; Pharmaceutical preparations for the prevention of pain; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely, menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and post-menopausal pain; suppositories for the prevention, treatment, or relief of pain; suppositories for the prevention, treatment, or relief of pain, namely, menstrual pain; vaginal suppositories for the prevention, treatment, or relief of pain; vaginal suppositories for the prevention, treatment, or relief of pain, namely, menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and post-menopausal pain; pre-menstrual, peri-menopausal, menopausal, and post-menopausal symptom treatment preparations; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely, tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the prevention, treatment, or relief of psychological disorders, namely, tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the treatment, prevention, or relief of inflammation, muscle cramping or spasticity, namely, tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for improving sleep quality or sleep duration, namely, tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids

Body and beauty care cosmetics; body and beauty care cosmetics containing cannabinoids; body and beauty care cosmetics containing cannabis; body and beauty care cosmetics containing cannabis derivatives ; body creams for cosmetic purposes; body lotions for cosmetic purposes; cannabinoid oil for cosmetic purposes; cannabis oil for cosmetic purposes; cannabis-based cosmetics; CBD cosmetics

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 7, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 7, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 4, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 4, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 20, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 20, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2023 NWOS
NEW APPLICATION ENTERED
Feb 27, 2023 NWAP